Influenza A Virus (H1N1) Infection Induces Glycolysis to Facilitate Viral Replication
Virologica Sinica · 2021-12 · 36 (6) · 1532-1542
DOI: 10.1007/s12250-021-00433-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virologica Sinica, online erschienen am 14.09.2021. Verfasst von Lehao Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, Ch…. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Influenza A virus. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Viruses depend on host cellular metabolism to provide the energy and biosynthetic building blocks required for their replication. In this study, we observed that influenza A virus (H1N1), a single-stranded, negative-sense RNA virus with an eight-segmented genome, enhanced glycolysis both in mouse lung tissues and in human lung epithelial (A549) cells. In detail, the expression of hexokinase 2 (HK2), the first enzyme in glycolysis, was upregulated in H1N1-infected A549 cells, and the expression of pyruvate kinase M2 (PKM2) and pyruvate dehydrogenase kinase 3 (PDK3) was upregulated in H1N1-infected mouse lung tissues. Pharmacologically inhibiting the glycolytic pathway or targeting hypoxia-inducible factor 1 (HIF-1), the central transcriptional factor critical for glycolysis, significantly reduced H1N1 replication, revealing a requirement for glycolysis during H1N1 infection. In addition, pharmacologically enhancing the glycolytic pathway further promoted H1N1 replication. Furthermore, the change of H1N1 replication upon glycolysis inhibition or enhancement was independent of interferon signaling. Taken together, these findings suggest that influenza A virus induces the glycolytic pathway and thus facilitates efficient viral replication. This study raises the possibility that metabolic inhibitors, such as those that target glycolysis, could be used to treat influenza A virus infection in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Microbiology Laboratory, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai, 200336, China.
- Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- Department of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.
- Department of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China. zgyi@fudan.edu.cn.
Zitieren
APA
Ren, L., Zhang, W., Zhang, J., Zhang, J., Zhang, H., Zhu, Y., Meng, X., Yi, Z., & Wang, R. (2021). Influenza A Virus (H1N1) Infection Induces Glycolysis to Facilitate Viral Replication. Virologica Sinica, 36(6), 1532-1542. https://doi.org/10.1007/s12250-021-00433-4
Vancouver
Ren L, Zhang W, Zhang J, Zhang J, Zhang H, Zhu Y, et al. Influenza A Virus (H1N1) Infection Induces Glycolysis to Facilitate Viral Replication. Virologica Sinica. 2021;36(6):1532-1542. doi:10.1007/s12250-021-00433-4
BibTeX
@article{Ren2021,
author = {Ren, Lehao and Zhang, Wanju and Zhang, Jing and Zhang, Jiaxiang and Zhang, Huiying and Zhu, Yong and Meng, Xiaoxiao and Yi, Zhigang and Wang, Ruilan},
title = {Influenza A Virus (H1N1) Infection Induces Glycolysis to Facilitate Viral Replication},
journal = {Virologica Sinica},
year = {2021},
volume = {36},
number = {6},
pages = {1532--1542},
doi = {10.1007/s12250-021-00433-4}
}
EUVIMED